OGDEN JOHN L 4

4 · PARALLAX HEALTH SCIENCES, INC. · Filed Nov 19, 2019

Form 4

Period: 2019-09-30

Director

Transactions

Award
STOCK OPTIONS
2019-01-01+250,000→ 1,000,000 total
Exercise: $0.25From: 2019-06-30Exp: 2024-01-01→ COMMON STOCK (250,000 underlying)
Award
STOCK OPTIONS
2019-01-01+250,000→ 1,250,000 total
Exercise: $0.25From: 2019-09-30Exp: 2024-01-01→ COMMON STOCK (250,000 underlying)
Purchase
WARRANTS
2019-09-30+1,200,000→ 2,700,000 total
Exercise: $0.25From: 2019-09-30Exp: 2022-09-30→ COMMON STOCK (1,200,000 underlying)
Purchase
COMMON STOCK (RESTRICTED)
2019-09-30$0.06/sh+1,200,000$75,000→ 3,516,964 total
Award
STOCK OPTIONS
2019-01-01+250,000→ 750,000 total
Exercise: $0.25From: 2019-03-31Exp: 2024-01-01→ COMMON STOCK (250,000 underlying)
Award
STOCK OPTIONS
2019-01-01+250,000→ 1,500,000 total
Exercise: $0.25From: 2019-12-31Exp: 2024-01-01→ COMMON STOCK (250,000 underlying)

Footnotes (3)

[F1]Issued in connection with a Securities Purchase Agreement dated September 30, 2019, for proceeds in the amount of $75,000, paid by way of reduction in accrued compensation.
[F2]Warrants granted in connection with Securities Purchase Agreement dated September 30, 2019.
[F3]Issued in connection with Consulting Agreement dated January 1, 2019.

Documents

1 file